• On 16 July 2026, T. Rowe Price announced the T. Rowe Price Active Crypto ETF (ticker: TKNZ), the first actively managed multi-token spot exchange-traded product, offering diversified exposure to crypto assets like Bitcoin, Ethereum, Binance, XRP, Solana, Hyperliquid, and others for a 0.75% management fee under a waiver through May 2027.
• This launch marks T. Rowe Price’s first product giving clients direct access to digital assets, extending its active management approach and in-house crypto trading infrastructure into a new asset class with a dedicated digital assets team.
• We’ll now examine how T. Rowe Price’s first actively managed, multi-token crypto ETP shapes its investment narrative around product innovation and growth.

AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

T. Rowe Price Group Investment Narrative Recap

To own T. Rowe Price, you need to believe its active management, brand, and distribution can offset fee pressure and competition from passive products. The new TKNZ crypto ETP broadens the product set, but it does not materially change the near term picture, where the key catalyst is growing ETF and retirement flows and the biggest risk remains sustained fee compression and equity outflows.

The TKNZ launch fits into a broader push to expand ETFs after products like the TPUT Capital Appreciation Market Opportunities ETF and a series of active equity and fixed income ETFs. These offerings speak directly to the current catalyst of diversifying beyond traditional mutual funds, while also highlighting the risk that newer vehicles often come with structurally lower fees, reinforcing concerns about long term margin pressure.

Yet behind the appeal of product innovation, investors should be aware of how ongoing fee compression and mix shift could...

T. Rowe Price Group's narrative projects $7.8 billion revenue and $1.9 billion earnings by 2029. This implies 1.9% yearly revenue growth and an earnings decrease of $0.1 billion from $2.0 billion today.

Uncover how T. Rowe Price Group's forecasts yield a $97.42 fair value, a 16% downside to its current price.

Exploring Other Perspectives

While TKNZ highlights product expansion, the most pessimistic analysts assume only 1.6 percent annual revenue growth and flat US$2.0 billion earnings, reminding you that expectations can differ widely.

Explore 7 other fair value estimates on T. Rowe Price Group - why the stock might be worth as much as 59% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your T. Rowe Price Group research is our analysis highlighting 4 key rewards that could impact your investment decision.
• Our free T. Rowe Price Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate T. Rowe Price Group's overall financial health at a glance.

Interested In Other Possibilities?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.